About
Resonance Health’s portfolio includes core lab and AI powered products for patient diagnosis and the management of diseases in relation to iron overload and metabolic diseases. Core products include solutions for assessment of Liver Iron Concentration, Cardiac Iron Concentration and Liver Fat.
We have extensive experience in providing quantitative imaging CRO services for multinational and multicentre clinical trials worldwide, using our core regulatory products as well as research use only products such as our non-invasive liver fibrosis assessment tool (currently in PoC trials).
For more information visit the Resonance Health website.
